全文获取类型
收费全文 | 12137篇 |
免费 | 644篇 |
国内免费 | 30篇 |
专业分类
耳鼻咽喉 | 187篇 |
儿科学 | 652篇 |
妇产科学 | 166篇 |
基础医学 | 1463篇 |
口腔科学 | 287篇 |
临床医学 | 781篇 |
内科学 | 2698篇 |
皮肤病学 | 365篇 |
神经病学 | 543篇 |
特种医学 | 287篇 |
外国民族医学 | 1篇 |
外科学 | 1795篇 |
综合类 | 356篇 |
一般理论 | 11篇 |
预防医学 | 568篇 |
眼科学 | 696篇 |
药学 | 1028篇 |
中国医学 | 57篇 |
肿瘤学 | 870篇 |
出版年
2023年 | 100篇 |
2022年 | 269篇 |
2021年 | 457篇 |
2020年 | 258篇 |
2019年 | 254篇 |
2018年 | 361篇 |
2017年 | 299篇 |
2016年 | 317篇 |
2015年 | 401篇 |
2014年 | 509篇 |
2013年 | 572篇 |
2012年 | 907篇 |
2011年 | 936篇 |
2010年 | 498篇 |
2009年 | 428篇 |
2008年 | 691篇 |
2007年 | 744篇 |
2006年 | 658篇 |
2005年 | 523篇 |
2004年 | 459篇 |
2003年 | 434篇 |
2002年 | 394篇 |
2001年 | 188篇 |
2000年 | 236篇 |
1999年 | 204篇 |
1998年 | 92篇 |
1997年 | 58篇 |
1996年 | 56篇 |
1995年 | 56篇 |
1994年 | 37篇 |
1993年 | 36篇 |
1992年 | 119篇 |
1991年 | 115篇 |
1990年 | 113篇 |
1989年 | 99篇 |
1988年 | 82篇 |
1987年 | 75篇 |
1986年 | 85篇 |
1985年 | 86篇 |
1984年 | 76篇 |
1983年 | 45篇 |
1981年 | 42篇 |
1980年 | 24篇 |
1979年 | 49篇 |
1978年 | 31篇 |
1977年 | 24篇 |
1975年 | 26篇 |
1974年 | 32篇 |
1973年 | 28篇 |
1972年 | 33篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
Dongbing Lai Emma C. Johnson Sarah Colbert Gayathri Pandey Grace Chan Lance Bauer Meredith W. Francis Victor Hesselbrock Chella Kamarajan John Kramer Weipeng Kuang Sally Kuo Samuel Kuperman Yunlong Liu Vivia McCutcheon Zhiping Pang Martin H. Plawecki Marc Schuckit Jay Tischfield Leah Wetherill Yong Zang Howard J. Edenberg Bernice Porjesz Arpana Agrawal Tatiana Foroud 《Alcoholism, clinical and experimental research》2022,46(3):374-383
2.
Harit Kapoor Kush Raj Lohani Tommy H. Lee Devendra K. Agrawal Sumeet K. Mittal 《CTS Clinical and Translational Science》2015,8(6):841-847
Esophageal adenocarcinoma is the fastest rising cancer in the United States. It develops from long‐standing gastroesophageal reflux disease which affects >20% of the general population. It carries a very poor prognosis with 5‐year survival <20%. The disease is known to sequentially progress from reflux esophagitis to a metaplastic precursor, Barrett''s esophagus and then onto dysplasia and esophageal adenocarcinoma. However, only few patients with reflux develop Barrett''s esophagus and only a minority of these turn malignant. The reason for this heterogeneity in clinical progression is unknown. To improve patient management, molecular changes which facilitate disease progression must be identified. Animal models can provide a comprehensive functional and anatomic platform for such a study. Rats and mice have been the most widely studied but disease homology with humans has been questioned. No animal model naturally simulates the inflammation to adenocarcinoma progression as in humans, with all models requiring surgical bypass or destruction of existing antireflux mechanisms. Valuable properties of individual models could be utilized to holistically evaluate disease progression. In this review paper, we critically examined the current animal models of Barrett''s esophagus, their differences and homologies with human disease and how they have shaped our current understanding of Barrett''s carcinogenesis. 相似文献
3.
Vinke Jeroen Kaper Hans J. Vissink Arjan Sharma Prashant K. 《Clinical oral investigations》2020,24(11):4019-4030
Clinical Oral Investigations - The aims of this study are to assess different saliva substitutes for their efficacy to lubricate the oral cavity, and to relate this oral lubrication to the ability... 相似文献
4.
Naveen B.S. M.T. Mohan J. Tharayil S.T. Joseph 《International journal of oral and maxillofacial surgery》2021,50(8):1003-1008
A local pedicled vascularized bone flap can prevent the morbidity and cost of free bone flap surgery in small segmental bone defects or long cartilaginous defects of the head and neck. Such flaps can also be useful in patients who are high risk for surgery. The periosteal vascularity of the mandible can be used to design islanded facial artery-based bone flaps, which can be utilized to that extent. Two patients with a small segmental mandibulectomy defect and one patient with a long cricotracheal resection defect underwent reconstruction using three different designs of islanded facial artery osteomyomucosal/osseous flap (iFOMM). The patients had a minimum follow-up period of 18 months. All flaps were successful, with satisfactory healing and without any functional deficit or disease at last follow-up. 相似文献
5.
6.
7.
8.
9.
10.
Ashutosh Singh M.Ch. Vidyut Kumar Sinha M.Ch. Jayant Khandekar M.Ch. Nandkishor Agrawal M.Ch. Anil Patwardhan M.Ch. Dr. Jagdish Kharideparkar M.Ch. 《Indian Journal of Thoracic and Cardiovascular Surgery》2006,22(2):121-125
Objective The degree of Left Ventricular Mass Index (LVMI) regression following aortic valve replacement correlates with long-term survival.
This study aims to assess the extent of LVMI regression at 3 months following aortic valve replacement (AVR) with different
types and sizes of mechanical valves in rheumatic aortic valve disease.
Methods The LVMI regression was studied in 34 consecutive patients, undergoing elective AVR for rheumatic aortic stenosis and/or regurgitation.
They were grouped in A and B, matched in age, body surface area and pre-operative LVMI, receiving respectively a tilting disc
and a bileaflet mechanical valve. The LVMI was calculated by M-mode echocardiography using the Devereux' formula pre-operatively
and three months post-operatively. The trend of LVMI reduction was compared between the two groups and amongst the patients
with stenotic, regurgitant and mixed aortic valve, pathologies; and receiving different sizes of valves.
Results The mean preoperative LVMI was 199g±79.5 g/m2. At three months post aortic valve replacement, the mean LVMI was 130g±49.0 g/m2. There was a significant reduction of LVMI post-operatively (p=0.001) at three months follow-up. The extent of LVMI regression
following surgery amongst the groups A and B did not vary significantly (p=0.92). The extent of LVMI regression did not vary
significantly in patients with different aortic valve pathology nor with different sizes of the valves implanted.
Conclusions There is a significant early LVMI regression following aortic valve replacement in rheumatic aortic valve disease. The type
and the size of the mechanical prosthesis or the rheumatic pathology do not appear to influence this regression. 相似文献